Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Assessment of Cannabidiol (CBD) Administrated in Oral Formulations

NCT03877991 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT03877991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03877991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Assessment of Cannabidiol (CBD) Administrated in Oral Formulations
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1
Overall status
Unknown status
Start date
February 19, 2024
Completion date
February 19, 2025
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain